Donor Noradrenaline Support Is Not Associated with Decreased Survival in Heart Transplant Recipients.
Daniel OehlerCharlotte BöttgerMoritz Benjamin ImmohrRaphael Romano BrunoJafer HaschemiDaniel ScheiberFabian VoßPatrick HornHug AubinIgor TudoracheRalf WestenfeldPayam AkhyariMalte KelmArtur LichtenbergUdo BoekenPublished in: Journal of clinical medicine (2022)
In this retrospective analysis, NE support in donors prior to heart transplantation was unrelated to differing survival after heart transplantation. However, higher doses of donor NE were associated with prolonged ventilation, longer duration on IMC/ICU, and a higher need for extracorporeal life support in recipients post-HTx.